Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population

Introduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition, tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic receptor 7 (GRM7) and N-acetyltransfer...

Full description

Bibliographic Details
Main Authors: Haúla F. Haider, Marisa Flook, Mariana Aparicio, Diogo Ribeiro, Marilia Antunes, Agnieszka J. Szczepek, Derek J. Hoare, Graça Fialho, João C. Paço, Helena Caria
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-11-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fnagi.2017.00346/full
_version_ 1811298717203955712
author Haúla F. Haider
Marisa Flook
Mariana Aparicio
Diogo Ribeiro
Marilia Antunes
Agnieszka J. Szczepek
Derek J. Hoare
Graça Fialho
João C. Paço
Helena Caria
Helena Caria
author_facet Haúla F. Haider
Marisa Flook
Mariana Aparicio
Diogo Ribeiro
Marilia Antunes
Agnieszka J. Szczepek
Derek J. Hoare
Graça Fialho
João C. Paço
Helena Caria
Helena Caria
author_sort Haúla F. Haider
collection DOAJ
description Introduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition, tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic receptor 7 (GRM7) and N-acetyltransferase 2 (NAT2) are some of the genetic markers for presbycusis.Objectives: To explore patterns of hearing loss and the role of GRM7 and NAT2 as possible markers of presbycusis and tinnitus in a Portuguese population sample.Materials and Methods: Tonal and speech audiometry, tinnitus assessment, clinical interview, and DNA samples were obtained from patients aged from 55 to 75 with or without tinnitus. GRM7 analysis was performed by qPCR. Genotyping of single nucleotide polymorphisms (SNPs) in NAT2 was performed by PCR amplification followed by Sanger sequencing or by qPCR.Results: We screened samples from 78 individuals (33 men and 45 women). T allele at GRM7 gene was the most observed (60.3% T/T and 33.3% A/T). Individuals with a T/T genotype have a higher risk for ARHL and 33% lower risk for tinnitus, compared to individuals with A/A and A/T genotype, respectively. Being a slow acetylator (53%) was the most common NAT2 phenotype, more common in men (55.8%). Intermediate acetylator was the second most common phenotype (35.9%) also more frequent in men (82.6%). Noise exposed individuals and individuals with ‘high frequency’ hearing loss seem to have a higher risk for tinnitus. Our data suggests that allele AT of GRM7 can have a statistically significant influence toward the severity of tinnitus.Conclusion: For each increasing year of age the chance of HL increases by 9%. The risk for ARHL was not significantly associated with GRM7 neither NAT2. However, we cannot conclude from our data whether the presence of T allele at GRM7 increases the odds for ARHL or whether the A allele has a protective effect. Genotype A/T at GRM7 could potentially be considered a biomarker of tinnitus severity. This is the first study evaluating the effect of GRM7 and NAT2 gene in tinnitus.
first_indexed 2024-04-13T06:23:23Z
format Article
id doaj.art-2ee2d47e70c14c24b18cce6831eae4a9
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-13T06:23:23Z
publishDate 2017-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-2ee2d47e70c14c24b18cce6831eae4a92022-12-22T02:58:31ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652017-11-01910.3389/fnagi.2017.00346299266Biomarkers of Presbycusis and Tinnitus in a Portuguese Older PopulationHaúla F. Haider0Marisa Flook1Mariana Aparicio2Diogo Ribeiro3Marilia Antunes4Agnieszka J. Szczepek5Derek J. Hoare6Graça Fialho7João C. Paço8Helena Caria9Helena Caria10ENT Department, Hospital Cuf Infante Santo, NOVA Medical School, Lisbon, PortugalDeafness Research Group, BTR Unit, BioISI, Faculty of Sciences, University of Lisbon (FCUL), Lisbon, PortugalFaculty of Sciences, University of Lisbon, Lisbon, PortugalENT Department, Hospital Cuf Infante Santo, NOVA Medical School, Lisbon, PortugalCentro de Estatística e Aplicações, Faculty of Sciences, University of Lisbon, Lisbon, PortugalDepartment of Otolaryngology, Charite University Hospital, Berlin, GermanyNIHR Nottingham Biomedical Research Centre, Division of Clinical Neuroscience, School of Medicine, University of Nottingham, Nottingham, United KingdomDeafness Research Group, BTR Unit, BioISI, Faculty of Sciences, University of Lisbon (FCUL), Lisbon, PortugalENT Department, Hospital Cuf Infante Santo, NOVA Medical School, Lisbon, PortugalDeafness Research Group, BTR Unit, BioISI, Faculty of Sciences, University of Lisbon (FCUL), Lisbon, PortugalESS/IPS- Biomedical Sciences Department, School of Health, Polytechnic Institute of Setubal, Setubal, PortugalIntroduction: Presbycusis or age-related hearing loss (ARHL) is a ubiquitous health problem. It is estimated that it will affect up to 1.5 billion people by 2025. In addition, tinnitus occurs in a large majority of cases with presbycusis. Glutamate metabotropic receptor 7 (GRM7) and N-acetyltransferase 2 (NAT2) are some of the genetic markers for presbycusis.Objectives: To explore patterns of hearing loss and the role of GRM7 and NAT2 as possible markers of presbycusis and tinnitus in a Portuguese population sample.Materials and Methods: Tonal and speech audiometry, tinnitus assessment, clinical interview, and DNA samples were obtained from patients aged from 55 to 75 with or without tinnitus. GRM7 analysis was performed by qPCR. Genotyping of single nucleotide polymorphisms (SNPs) in NAT2 was performed by PCR amplification followed by Sanger sequencing or by qPCR.Results: We screened samples from 78 individuals (33 men and 45 women). T allele at GRM7 gene was the most observed (60.3% T/T and 33.3% A/T). Individuals with a T/T genotype have a higher risk for ARHL and 33% lower risk for tinnitus, compared to individuals with A/A and A/T genotype, respectively. Being a slow acetylator (53%) was the most common NAT2 phenotype, more common in men (55.8%). Intermediate acetylator was the second most common phenotype (35.9%) also more frequent in men (82.6%). Noise exposed individuals and individuals with ‘high frequency’ hearing loss seem to have a higher risk for tinnitus. Our data suggests that allele AT of GRM7 can have a statistically significant influence toward the severity of tinnitus.Conclusion: For each increasing year of age the chance of HL increases by 9%. The risk for ARHL was not significantly associated with GRM7 neither NAT2. However, we cannot conclude from our data whether the presence of T allele at GRM7 increases the odds for ARHL or whether the A allele has a protective effect. Genotype A/T at GRM7 could potentially be considered a biomarker of tinnitus severity. This is the first study evaluating the effect of GRM7 and NAT2 gene in tinnitus.http://journal.frontiersin.org/article/10.3389/fnagi.2017.00346/fullpresbycusisGRM7NAT2tinnitusmarkerscomorbidities
spellingShingle Haúla F. Haider
Marisa Flook
Mariana Aparicio
Diogo Ribeiro
Marilia Antunes
Agnieszka J. Szczepek
Derek J. Hoare
Graça Fialho
João C. Paço
Helena Caria
Helena Caria
Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
Frontiers in Aging Neuroscience
presbycusis
GRM7
NAT2
tinnitus
markers
comorbidities
title Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
title_full Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
title_fullStr Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
title_full_unstemmed Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
title_short Biomarkers of Presbycusis and Tinnitus in a Portuguese Older Population
title_sort biomarkers of presbycusis and tinnitus in a portuguese older population
topic presbycusis
GRM7
NAT2
tinnitus
markers
comorbidities
url http://journal.frontiersin.org/article/10.3389/fnagi.2017.00346/full
work_keys_str_mv AT haulafhaider biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT marisaflook biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT marianaaparicio biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT diogoribeiro biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT mariliaantunes biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT agnieszkajszczepek biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT derekjhoare biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT gracafialho biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT joaocpaco biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT helenacaria biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation
AT helenacaria biomarkersofpresbycusisandtinnitusinaportugueseolderpopulation